Literature DB >> 12666122

Diminished striatal [123I]iodobenzovesamicol binding in idiopathic cervical dystonia.

Roger L Albin1, Donna Cross, Wayne T Cornblath, John A Wald, Kristine Wernette, Kirk A Frey, Satoshi Minoshima.   

Abstract

Striatal dysfunction is thought to underlie many dystonias. We used [(123)I]iodobenzovesamicol single-photon emission computed tomography imaging to determine the density of cholinergic terminals in the striatum and other brain regions in 13 subjects with idiopathic cervical dystonia. Striatal [(131)I]iodobenzovesamicol binding was reduced. These results support a role for striatal dysfunction in idiopathic dystonias and suggest diminished striatal cholinergic interneuron density in cervical dystonia.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12666122     DOI: 10.1002/ana.10527

Source DB:  PubMed          Journal:  Ann Neurol        ISSN: 0364-5134            Impact factor:   10.422


  10 in total

1.  Heteroaromatic and aniline derivatives of piperidines as potent ligands for vesicular acetylcholine transporter.

Authors:  Junfeng Li; Xiang Zhang; Zhanbin Zhang; Prashanth K Padakanti; Hongjun Jin; Jinquan Cui; Aixiao Li; Dexing Zeng; Nigam P Rath; Hubert Flores; Joel S Perlmutter; Stanley M Parsons; Zhude Tu
Journal:  J Med Chem       Date:  2013-07-18       Impact factor: 7.446

2.  Striatal dopamine D1-like receptor binding is unchanged in primary focal dystonia.

Authors:  Morvarid Karimi; Stephen M Moerlein; Tom O Videen; Yi Su; Hubert P Flores; Joel S Perlmutter
Journal:  Mov Disord       Date:  2013-10-21       Impact factor: 10.338

3.  Pedunculopontine Nucleus Cholinergic Deficiency in Cervical Dystonia.

Authors:  Karin Mente; Nancy A Edwards; Demelio Urbano; Abhik Ray-Chaudhury; Diego Iacono; Ana Tereza Di Lorenzo Alho; Eduardo Joaquim Lopes Alho; Edson Amaro; Silvina G Horovitz; Mark Hallett
Journal:  Mov Disord       Date:  2018-03-06       Impact factor: 10.338

4.  Syntheses and radiosyntheses of two carbon-11 labeled potent and selective radioligands for imaging vesicular acetylcholine transporter.

Authors:  Prashanth K Padakanti; Xiang Zhang; Junfeng Li; Stanley M Parsons; Joel S Perlmutter; Zhude Tu
Journal:  Mol Imaging Biol       Date:  2014-12       Impact factor: 3.488

5.  Positron emission tomography imaging of (2R,3R)-5-[(18)F]fluoroethoxybenzovesamicol in rat and monkey brain: a radioligand for the vesicular acetylcholine transporter.

Authors:  Michael R Kilbourn; Brian Hockley; Lihsueh Lee; Phillip Sherman; Carole Quesada; Kirk A Frey; Robert A Koeppe
Journal:  Nucl Med Biol       Date:  2009-05-08       Impact factor: 2.408

6.  Forebrain deletion of the dystonia protein torsinA causes dystonic-like movements and loss of striatal cholinergic neurons.

Authors:  Samuel S Pappas; Katherine Darr; Sandra M Holley; Carlos Cepeda; Omar S Mabrouk; Jenny-Marie T Wong; Tessa M LeWitt; Reema Paudel; Henry Houlden; Robert T Kennedy; Michael S Levine; William T Dauer
Journal:  Elife       Date:  2015-06-08       Impact factor: 8.140

7.  A cell autonomous torsinA requirement for cholinergic neuron survival and motor control.

Authors:  Samuel S Pappas; Jay Li; Tessa M LeWitt; Jeong-Ki Kim; Umrao R Monani; William T Dauer
Journal:  Elife       Date:  2018-08-17       Impact factor: 8.140

Review 8.  Convergent evidence for abnormal striatal synaptic plasticity in dystonia.

Authors:  David A Peterson; Terrence J Sejnowski; Howard Poizner
Journal:  Neurobiol Dis       Date:  2009-12-18       Impact factor: 5.996

9.  Striatal Cholinergic Interneurons in a Knock-in Mouse Model of L-DOPA-Responsive Dystonia.

Authors:  Gul Yalcin-Cakmakli; Samuel J Rose; Rosa M Villalba; Lagena Williams; Hyder A Jinnah; Ellen J Hess; Yoland Smith
Journal:  Front Syst Neurosci       Date:  2018-06-27

10.  Vesicular Acetylcholine Transporter Alters Cholinergic Tone and Synaptic Plasticity in DYT1 Dystonia.

Authors:  Annalisa Tassone; Giuseppina Martella; Maria Meringolo; Valentina Vanni; Giuseppe Sciamanna; Giulia Ponterio; Paola Imbriani; Paola Bonsi; Antonio Pisani
Journal:  Mov Disord       Date:  2021-06-26       Impact factor: 9.698

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.